Healthcare Global Enterprises

539.40
-11.50
(-2.09%)
ann
Q4 Quarterly Results are out. Check out the updated financials2 days ago
Viewcross
right
Market Cap
7,680.40 Cr
EPS
3.46
PE Ratio
172.34
Dividend Yield
0.00 %
52 Week High
639.00
52 Week Low
330.65
PB Ratio
8.31
Debt to Equity
1.29
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+75.00 %
+75.00 %
Hold
Hold+25.00 %
+25.00 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
neutral
Healthcare Global Enterprises Ltd Reports Q4 Financial Results3 days ago
Healthcare Global Enterprises Ltd has announced its quarterly financial results. The company reported a consolidated net profit of 67 million rupees, compared to 234 million rupees in the same quarter last year and 77 million rupees in the previous quarter. Revenue for the quarter stood at 5.83 billion rupees, up from 4.93 billion rupees year-over-year and 5.57 billion rupees quarter-over-quarter.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,135.20
#1 1,10,357.57
98.86
5,584.10
18.77
#1 1,058
26.84
51.53
6,923.00
99,542.12
76.28
#1 19,165.50
14.74
917
49.14
50.68
716.30
54,077.65
63.40
6,931.20
8.99
645
-7.43
58.47
1,764.80
36,065.59
#1 44.21
5,093.40
10.96
790
3.41
45.69
1,197.10
32,152.60
62.62
2,759.20
#1 25.09
326
-20.35
49.96
541.00
27,023.66
73.01
3,723.70
22.85
205
#1 3,986.36
52.05
649.15
26,083.10
69.19
2,511.20
12.94
336
48.39
51.21
1,399.30
14,210.13
58.71
1,334.00
10.76
218
10.57
57.52
1,443.80
9,486.70
49.01
1,095.50
21.32
177
-0.88
49.82
539.40
#10 7,680.40
#10 172.34
#8 1,929.10
#6 12.97
#10 41
#10 -71.06
44.42
Forecast
Actual
Growth Rate
Revenue Growth
12.97 %
Net Income Growth
134.66 %
Cash Flow Change
13.11 %
ROE
135.47 %
ROCE
5.76 %
EBITDA Margin (Avg.)
-1.64 %

Quarterly Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
133
142
143
143
156
170
176
178
186
194
219
212
229
228
248
250
261
270
279
279
271
195
251
279
302
326
495
360
367
410
421
428
446
463
489
475
502
534
564
563
594
Expenses
115
123
127
125
131
144
149
150
153
162
180
180
191
198
213
222
231
228
238
234
236
176
218
245
343
272
292
342
302
336
345
349
365
386
402
391
403
435
451
470
480
EBITDA
19
19
17
18
25
26
28
28
34
32
39
32
38
30
34
28
30
43
42
45
35
19
33
34
-41
55
202
18
65
74
76
78
80
76
87
84
100
99
112
93
114
Operating Profit %
13 %
13 %
11 %
12 %
15 %
14 %
15 %
15 %
16 %
15 %
15 %
13 %
14 %
13 %
13 %
11 %
10 %
15 %
14 %
15 %
12 %
8 %
12 %
10 %
-16 %
16 %
17 %
4 %
17 %
18 %
18 %
18 %
17 %
16 %
17 %
17 %
18 %
17 %
18 %
16 %
18 %
Depreciation
10
11
11
11
12
13
14
15
15
15
17
18
21
20
21
22
23
34
35
38
42
39
40
42
38
38
38
41
41
40
41
41
42
41
43
44
46
47
50
57
58
Interest
9
9
9
10
11
5
6
5
7
7
10
10
15
18
24
13
16
31
35
36
36
37
27
29
26
26
23
24
24
25
26
27
26
26
27
30
27
34
36
41
44
Profit Before Tax
0
0
-1
-1
2
8
8
8
12
10
12
4
2
-8
-10
-7
-8
-23
-27
-28
-42
-57
-32
-35
-104
-9
142
-46
1
10
10
11
13
11
18
11
28
19
28
-3
14
Tax
0
-0
-1
1
-2
3
3
3
4
4
2
2
2
-1
-3
-1
3
-2
-2
1
9
-11
-5
-1
9
4
43
4
-1
8
5
7
8
7
7
8
5
5
7
-11
7
Net Profit
0
1
-1
-2
4
5
5
5
8
6
10
1
-0
-6
-8
-6
-11
-21
-25
-29
-50
-46
-27
-35
-114
-13
99
-50
2
3
5
4
6
4
11
3
24
14
21
8
7
EPS in ₹
-0.04
-0.07
-0.23
-0.30
0.44
0.59
0.58
0.63
0.90
0.55
1.17
0.37
0.30
-0.39
-0.74
-0.71
-0.99
-2.05
-2.51
-2.57
-4.91
-4.48
-1.94
-2.33
-8.14
-0.76
8.22
-3.55
0.43
0.44
0.53
0.54
0.60
0.55
0.97
0.41
1.53
0.87
1.29
0.50
0.53

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
776
1,034
1,226
1,444
1,654
2,253
2,036
2,220
2,316
2,708
Fixed Assets
529
568
685
828
970
1,646
1,382
1,547
1,553
1,758
Current Assets
122
201
244
220
273
304
435
502
580
680
Capital Work in Progress
42
155
148
174
153
46
30
22
18
83
Investments
0
60
11
53
49
34
26
9
10
10
Other Assets
205
252
382
389
482
527
597
642
735
856
Total Liabilities
776
1,034
1,226
1,444
1,654
2,253
2,036
2,220
2,316
2,708
Current Liabilities
187
195
366
359
547
576
465
470
570
744
Non Current Liabilities
284
270
371
506
584
1,258
856
866
876
1,099
Total Equity
305
569
490
579
522
420
714
884
869
865
Reserve & Surplus
209
451
347
398
389
293
528
731
721
687
Share Capital
70
85
86
87
88
89
125
139
139
139

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
3
85
-29
-24
-56
-30
62
190
-22
-5
Investing Activities
-79
-204
-210
-283
-238
-101
-171
125
-133
-226
Operating Activities
60
73
91
98
99
130
121
220
252
285
Financing Activities
22
216
89
161
84
-58
112
-155
-140
-64

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Promoter
70.71 %
68.41 %
68.40 %
71.44 %
71.43 %
71.42 %
71.39 %
71.38 %
71.37 %
71.35 %
71.30 %
71.29 %
71.28 %
71.25 %
71.23 %
71.23 %
71.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
6.28 %
0.00 %
6.74 %
3.95 %
4.29 %
2.77 %
2.45 %
DIIs
7.82 %
7.86 %
6.27 %
5.52 %
4.90 %
3.56 %
4.03 %
4.40 %
5.54 %
6.58 %
7.94 %
6.66 %
8.52 %
10.89 %
11.64 %
12.94 %
12.47 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
7.05 %
9.46 %
10.83 %
10.07 %
10.84 %
11.58 %
11.21 %
11.60 %
11.44 %
10.43 %
9.96 %
9.68 %
9.39 %
9.41 %
9.33 %
9.60 %
10.43 %
Others
14.42 %
14.26 %
14.50 %
12.97 %
12.83 %
13.44 %
13.38 %
12.61 %
11.65 %
11.63 %
4.52 %
12.37 %
4.07 %
4.49 %
3.50 %
3.46 %
3.43 %
No of Share Holders
13,891
15,065
20,573
22,362
23,663
23,018
24,672
28,707
28,858
25,931
27,327
27,289
27,195
26,529
29,670
32,820
45,394

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
24 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 May 2025 550.30 594.65
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Feb 2025 531.05 510.60
09 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
09 Nov 2024 423.60 468.10
25 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Sept 2024 399.45 421.10

Announcements

Compliances-Reg.24(A)-Annual Secretarial Compliance2 days ago
Earnings Call Held With Analysts/Investors To Discuss The Audited Financial Results Of The Quarter And Year Ended March 31 20253 days ago
Announcement under Regulation 30 (LODR)-Newspaper Publication3 days ago
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations 20154 days ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release4 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation4 days ago
Integrated Filing (Financial)4 days ago
Board Meeting Outcome for Annual Financial Results (Standalone And Consolidated) For Quarter And Year Ended March 31 20254 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 12, 2025
Board Meeting Intimation for Considering Approving And Taking On Record The Audited Financial Results (Both Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2025 (Audited Financial Results).May 12, 2025
Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 08, 2025
Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)May 02, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportApr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 21, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 17, 2025
Announcement Under Regulation 30Apr 16, 2025
Clarification sought from HealthCare Global Enterprises LtdApr 16, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 29, 2025
Closure of Trading WindowMar 29, 2025
Cautionary E-Mail From BSE Limited Dated March 28 2025Mar 28, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 28, 2025
Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011.Mar 19, 2025
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations 2011Mar 19, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesMar 17, 2025
Announcement under Regulation 30 (LODR)-Open Offer - UpdatesMar 11, 2025
Draft Letter of OfferMar 11, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMar 06, 2025
Announcement Under Regulation 30 Of SEBI (LODR) RegulationsMar 03, 2025
Detailed Public StatementMar 03, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 27, 2025
Disclosure under Regulation 30A of LODRFeb 25, 2025
Integrated Filing (Financial)Feb 24, 2025
Public Announcement - Open OfferFeb 24, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 23, 2025
Announcement under Regulation 30 (LODR)-Public Announcement-Open OfferFeb 23, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 23, 2025
Announcement Under Regulation 30Feb 23, 2025
Announcement Under Regulation 30Feb 23, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 23, 2025
Board Meeting Outcome for Disclosure Under Regulation 30Feb 23, 2025
Announcment Under Regulation 30- Rescheduling Of Earnings CallFeb 19, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 17, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 16, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 15, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 14, 2025
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024Feb 14, 2025
Results- Financial Results For Decembe 31 2024Feb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 11, 2025

Technical Indicators

RSI(14)
Neutral
44.42
ATR(14)
Less Volatile
26.37
STOCH(9,6)
Neutral
32.23
STOCH RSI(14)
Oversold
5.93
MACD(12,26)
Bearish
-7.24
ADX(14)
Weak Trend
20.07
UO(9)
Bearish
38.23
ROC(12)
Downtrend And Accelerating
-4.27
WillR(14)
Neutral
-78.03

Mutual Fund Holdings

Funding HouseNo of SharesCurrent Holding %1M Change %3M Change %Month
Samco Multi Cap Fund Direct-Growth
0
0.00%
-0.57%
-0.54%
Apr 2025
Motilal Oswal Multi Cap Fund Direct - Growth
2580559
4.19%
0.27%
-0.74%
Apr 2025
Motilal Oswal Business Cycle Fund Direct-Growth
1750000
5.64%
0.22%
0.16%
Apr 2025
ITI Pharma and Healthcare Fund Direct - Growth
63013
1.62%
-0.10%
-0.08%
Apr 2025
Samco Special Opportunities Fund Direct - Growth
97063
3.65%
0.09%
0.14%
Apr 2025
Tata Small Cap Fund Direct - Growth
3347532
2.00%
0.03%
-0.03%
Apr 2025
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
117843
0.33%
0.01%
-0.01%
Apr 2025
Tata India Pharma & Healthcare Fund Direct-Growth
666121
3.06%
0.01%
0.49%
Apr 2025
Tata Focused Equity Fund Direct - Growth
758709
2.42%
0.01%
0.09%
Apr 2025
Nippon India ELSS Tax Saver Fund Direct-Growth
3500000
1.33%
0.01%
0.02%
Apr 2025
Mirae Asset Nifty Total Market Index Fund Direct-Growth
83
0.01%
0.00%
0.00%
Apr 2025
Sundaram Long Term Tax Advantage Fund Series II Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Nippon India Pharma Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
ICICI Prudential Exports and Services Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
Angel One Nifty Total Market Index Fund Direct - Growth
71
0.01%
0.00%
0.01%
Apr 2025
Sundaram Long Term Tax Advantage Fund Series III Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
Sundaram Long Term Tax Advantage Fund Series IV Direct - Growth
0
0.00%
0.00%
0.00%
Apr 2025
Tata Equity Savings Fund Direct-Growth
0
0.00%
0.00%
0.00%
Apr 2025
Groww Nifty Total Market Index Fund Direct - Growth
599
0.01%
0.00%
0.00%
Apr 2025
Bandhan Nifty Total Market Index Fund Direct-Growth
81
0.01%
0.00%
0.00%
Apr 2025